Department of Molecular Pathology, Osaka City University Graduate School of Medicine, Abeno-ku, 1-4-3 Asahi-machi, Osaka 545-8585, Japan.
Department of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Abeno-ku, 1-4-3 Asahi-machi, Osaka 545-8585, Japan.
Int J Mol Sci. 2020 Oct 20;21(20):7746. doi: 10.3390/ijms21207746.
To uncover mechanisms and explore novel biomarkers of obesity, type 2 diabetes (T2DM) and nonalcoholic steatohepatitis (NASH)-associated hepatocarcinogenesis, cellular and molecular alterations in the liver, and hepatocellular carcinomas (HCCs) were investigated in NASH model 60-week-old Tsumura, Suzuki, Obese Diabetic (TSOD) mice and NASH HCC patients. Markedly elevated lipid deposition, inflammation, fibrosis, and peroxisome proliferation in the liver, preneoplastic lesions, and HCCs of TSOD mice were accompanied by accumulation of polysaccharides in the cellular cytoplasm and nuclei and increase of oxidative DNA damage marker, 8-hydroxydeoxyguanosine (8-OHdG) formation in the liver and altered foci. Metabolomics of TSOD mice HCCs demonstrated significant elevation of the concentration of amino acid L-arginine, phosphocreatine, -adenosylmethionine/-adenosylhomocysteine ratio, adenylate, and guanylate energy charges in coordination with tremendous rise of glucose metabolites, mostly fructose 1,6-diphosphate. L-arginine accumulation in HCCs was associated with significant under-expression of arginase 1 (ARG1), suppression of the urea cycle, methionine and putrescine degradation pathways, activation of Ser and Thr kinase Akt AKT, phosphoinositide 3-kinase (PI3K), extracellular signal-regulated kinase 1/2 (ERK1/2) kinases, β-catenin, mammalian target of rapamycin (mTOR), and cell proliferation. Furthermore, clinicopathological analysis in 20 metabolic syndrome/NASH and 80 HCV-positive HCC patients demonstrated significant correlation of negative ARG1 expression with poor tumor differentiation, higher pathological stage, and significant decrease of survival in metabolic syndrome/NASH-associated HCC patients, thus indicating that ARG1 could become a potential marker for NASH HCC. From these results, formation of oxidative stress and 8-OHdG in the DNA and elevation of glucose metabolites and L-arginine due to ARG1 suppression in mice liver cells are the important characteristics of T2DM/NASH-associated hepatocarcinogenesis, which may take part in activating oxidative stress resistance, synthesis of phosphocreatine, cell signaling, methylation, and proliferation.
为了揭示肥胖、2 型糖尿病(T2DM)和非酒精性脂肪性肝炎(NASH)相关肝细胞癌发生的机制并探索新的生物标志物,我们研究了 NASH 模型 60 周龄的 Tsumura、Suzuki、Obese Diabetic(TSOD)小鼠和 NASH 肝癌患者的肝脏、肝癌前病变和肝癌中的细胞和分子改变。TSOD 小鼠的肝脏中脂质沉积、炎症、纤维化和过氧化物酶体增殖明显增加,伴有细胞质和细胞核中多糖的积累,以及氧化 DNA 损伤标志物 8-羟基脱氧鸟苷(8-OHdG)形成和改变的焦点增加。TSOD 小鼠肝癌的代谢组学研究表明,L-精氨酸、磷酸肌酸、-腺苷甲硫氨酸/-腺苷同型半胱氨酸比、腺苷酸和鸟苷酸能量电荷的浓度显著升高,同时葡萄糖代谢物也显著升高,主要是果糖 1,6-二磷酸。肝癌中 L-精氨酸的积累与精氨酸酶 1(ARG1)的显著下调、尿素循环、蛋氨酸和腐胺降解途径的抑制、丝氨酸和苏氨酸激酶 Akt AKT、磷酸肌醇 3-激酶(PI3K)、细胞外信号调节激酶 1/2(ERK1/2)激酶、β-连环蛋白、哺乳动物雷帕霉素靶蛋白(mTOR)和细胞增殖的激活有关。此外,对 20 例代谢综合征/NASH 和 80 例 HCV 阳性肝癌患者的临床病理分析表明,ARG1 表达阴性与肿瘤分化差、病理分期高和代谢综合征/NASH 相关肝癌患者生存率显著下降显著相关,因此表明 ARG1 可能成为 NASH 肝癌的潜在标志物。综上所述,在小鼠肝细胞中,氧化应激和 DNA 中的 8-OHdG 的形成以及由于 ARG1 抑制导致的葡萄糖代谢物和 L-精氨酸的升高是 T2DM/NASH 相关肝细胞癌发生的重要特征,可能参与激活氧化应激抵抗、磷酸肌酸合成、细胞信号转导、甲基化和增殖。